Dr Reddys Laboratories (RDY) Net Margin (2009 - 2026)

Dr Reddys Laboratories has reported Net Margin for 18 years, with the latest figure at 5.5% in Q2 2026.

• On a quarterly basis, Net Margin fell 1110.0% year-over-year to 5.5% in Q2 2026; TTM through Jun 2026 was 0.34%, a 1027.0% decrease from a year earlier, with the FY2026 full-year figure at 13.56%, down 464.0% from the prior year.
• Net Margin was 5.5% for Q2 2026 at Dr Reddys Laboratories, up from 0.49% in the prior quarter.
• The five-year high for Net Margin was 22.77% in Q2 2022, with the low at 20.71% in Q4 2025.
• Average Net Margin over 5 years is 12.26%, with a median of 16.75% recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Net Margin surged 1923 bps in 2023, then tumbled 3762 bps in 2025.
• Over 5 years, Net Margin stood at 15.25% in 2022, then gained by 25 bps to 19.11% in 2023, then decreased by 12 bps to 16.91% in 2024, then sank by 223 bps to 20.71% in 2025, then jumped by 127 bps to 5.5% in 2026.
• The last three Net Margin figures came in at 5.5% (Q2 2026), 0.49% (Q1 2026), and 20.71% (Q4 2025), per Business Quant data.